Immunogenicity and Protective Efficacy of Candidate Universal Influenza A Nanovaccines Produced in Plants by Tobacco Mosaic Virus-based Vectors

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|31|5587-5600

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.31, 2013-09, pp. : 5587-5600

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Vero cell-based seasonal influenza vaccine candidate may be promising for immunogenicity across three seasonal influenza strains

By  

Inpharma, Vol. 1, Iss. 1599, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Evaluation of Risks Related to the Use of Adeno-Associated Virus-Based Vectors

By  

Current Gene Therapy, Vol. 3, Iss. 6, 2003-12 ,pp. : 545-565

Bentham Science Publishers

Access to resources Recommend Favorite

Peptide-Based Subunit Nanovaccines

By  

Current Drug Delivery, Vol. 8, Iss. 3, 2011-05 ,pp. : 282-289

Bentham Science Publishers

Access to resources Recommend Favorite

Animal models to assess the toxicity, immunogenicity and effectiveness of candidate influenza vaccines

By Eichelberger Maryna C   Green Martin D  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 9, 2011-09 ,pp. : 1117-1127

Informa Healthcare

Access to resources Recommend Favorite

Virus-Based Gene Delivery Systems

By Mah C.   Byrne B.J.   Flotte T.R.  

Clinical Pharmacokinetics, Vol. 41, Iss. 12, 2002-01 ,pp. : 901-911

Adis International

Access to resources Recommend Favorite